Cargando…
Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder
CRISPR‐Cas9–generated zebrafish carrying a 12 base‐pair deletion in stxbpb1b, a paralog sharing 79% amino acid sequence identity with human, exhibit spontaneous electrographic seizures during larval stages of development. Zebrafish stxbp1b mutants provide an efficient preclinical platform to test an...
Autores principales: | Moog, Maia, Baraban, Scott C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436285/ https://www.ncbi.nlm.nih.gov/pubmed/35451230 http://dx.doi.org/10.1002/epi4.12604 |
Ejemplares similares
-
Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet Syndrome treatment
por: Baraban, Scott C., et al.
Publicado: (2013) -
In vivo calcium imaging reveals disordered interictal network dynamics in epileptic stxbp1b zebrafish
por: Liu, Jing, et al.
Publicado: (2021) -
Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish
por: Grone, Brian P., et al.
Publicado: (2016) -
Genotype-phenotype correlations of STXBP1 pathogenic variants and the treatment choices for STXBP1-related disorders in China
por: Kessi, Miriam, et al.
Publicado: (2023) -
Isoconazole and Clemizole Hydrochloride Partially Reverse the Xeroderma Pigmentosum C Phenotype
por: Kobaisi, Farah, et al.
Publicado: (2021)